Christopher E. Ware, senior vice president, general counsel and corporate secretary at Itron Inc (NASDAQ:ITRI), disposed of 4,486 shares of company common stock on February 19, 2026, according to a Form 4 filing with the Securities and Exchange Commission.
The sale occurred at $99.5385 per share and produced total gross proceeds of $446,529. The filing states the transaction was carried out to meet tax withholding obligations arising from the vesting of a performance-based restricted stock unit award. After the transaction, Ware is reported to directly hold 31,806 shares of Itron common stock.
Those insider disclosures arrived as Itron released its fourth-quarter 2025 financial results. The company posted earnings per share of $2.46 for the quarter, ahead of the consensus estimate of $2.19. Revenue for the period reached $572 million, topping the projected $561.48 million.
Market and analyst responses followed the company’s reported quarterly performance. Oppenheimer raised its price target on Itron shares to $133 from $125 while maintaining an Outperform rating. Baird also moved its rating to Outperform from Neutral and increased its price target to $128 from $118, citing what the firm described as a sizable opportunity related to utility grid modernization.
In addition to earnings and analyst commentary, Itron announced plans to offer $600 million in convertible senior notes due 2032 to qualified institutional buyers. The company said initial purchasers will have an option to acquire up to an additional $90 million in notes.
Combined, the insider filing, quarterly results, analyst revisions and debt offering form the latest corporate developments disclosed by Itron. The Form 4 filing documents the stock sale as a tax-related transaction linked to RSU vesting, while the earnings release and subsequent analyst actions reflect the company’s most recent operating performance. The convertible note offering was presented as part of Itron’s capital market activity.
Details in the SEC filing specify the number of shares sold, the exact sale price and the reason for the sale. Separately reported financial figures and the convertible notes announcement were included in the company’s public disclosures and in subsequent analyst commentary.
No additional claims about motive or future outcomes were indicated in the filings and announcements referenced in this report.